Hetero’s copy of COVID-19 drug Tocilizumab gets EUA from DCGI
The Hindu
A biosimilar version of Roche’s Actemra/RoActemra, product will be available by month end.
Drugmaker Hetero’s generic version of Tocilizumab has recieved Emergency Use Authorisation (EUA) from the Drugs Controller General of India (DCGI). A biosimilar version of Roche’s Actemra/RoActemra, the product (Tocilizumab 400mg/20ml) is to marketed under the Tocira brand name. It will be available by September end, Hetero said in a release on Monday. The EUA will enable medical practitioners to use the generic drug for treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO), it said.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Rupee closes at 86.64 against dollar, facing pressure from strong U.S. dollar and foreign fund outflows.
Benchmark indices Sensex and Nifty close higher on third consecutive day, led by heavyweight stocks; market outlook remains volatile.
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
Nissan cuts U.S. production, offers buyouts to workers in global restructuring plan to boost profitability.
Finance Minister Nirmala Sitharaman to present record eighth consecutive Union Budget, focusing on economic growth and middle-class relief.
Deputy Commissioner of Police in Manesar imposes prohibitory orders ahead demonstration by temporary Maruti workers, sparking criticism from labour rights activists.
SoftBank is in talks to invest as much as $25 billion into OpenAI, the Financial Times reported.
Benchmark indices Sensex and Nifty rebounded, led by Bajaj Finance and Bajaj Finserv, despite early losses and FII selling.
Rupee weakens against US dollar due to FED's hawkish outlook, foreign fund outflows, and domestic market trends.
According to the company, the technology, protected by multiple international patents, facilitates the creation of a plastic-to-plastic circular economy, where commonly used plastics such as polyolefin packaging no longer need to be down-cycled, incinerated or landfilled at the end of their life. Instead, they can be continuously recycled in a closed-loop, without any loss of quality.
Meta beat Wall Street expectations for fourth-quarter revenue on Wednesday but predicted sales in the current first quarter may not meet forecasts.
Union Budget 2025: Analysis of Indian economy's growth patterns, fiscal spending, and impact on consumption trends, highlighting need for policy changes.
OpenAI warns of Chinese companies reverse engineering AI models, sparking tensions over intellectual property protection.
NCLT orders inquiry against Byju's resolution professional, restores Aditya Birla Finance as financial creditor, nullifies CoC reconstitution.
U.K. Chancellor Rachel Reeves signals that Britain was not destined to decline, announces a slew of projects and regulatory changes.
The Centre on January 29 urged airlines to maintain ‘reasonable fares’ for devotees making their way to Prayagraj for the ongoing Maha Kumbh. IndiGo said it has slashed down ticket prices by 30% to 50% on flights to and from the pilgrim city.
The Centre on January 29 urged airlines to maintain ‘reasonable fares’ for devotees making their way to Prayagraj for the ongoing Maha Kumbh. IndiGo said it has slashed down ticket prices by 30% to 50% on flights to and from the pilgrim city.
Union Budget 2024 slashes agriculture subsidies, farmers demand MSP implementation, loan waivers, and comprehensive crop insurance in 2025 Budget.